You searched for "nAMD"
Transfected RPE cells inhibit AMD in rats
1 August 2015
| Graham Wallace
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. Wet AMD is characterised by choroidal neovascularisation, new vessels into the retina, leading to leakage and tissue damage. Many proangiogenic factors particularly vascular endothelial growth factor (VEGF)...
Guilty till proven otherwise! @ 100% Ophthalmology
25 February 2024
@10:15 – 11:15
Picture quiz on eyelid tumours.
AI in anterior segment disease - what you need to know! @ 100% Ophthalmology
25 February 2024
@11:30 – 12:30
Everything you need to understand before you start to consider using AI in your practice with a focus on anterior segment disease!
Handheld OCT in children @ 100% Ophthalmology
25 February 2024
@12:45 – 13:45
This session will provide an exciting overview of handheld OCT applications in children, relevant to a general audience. This will include clinical applications across numerous conditions, tips for successful image acquisition, and research updates.
21st century cataract surgery training - a global perspective & cybersight @ 100% Ophthalmology
25 February 2024
@15:15 – 16:15
Orbis’s online training and mentorship service for eye health professionals in developing countries.
Research is everyone’s business @ 100% Ophthalmology
25 February 2024
@16:15 – 17:00
The NHS Constitution pledges to inform patients of research studies in which they may be eligible to participate. The NHS Long Term Plan states that research will play a key part in improving the quality of patient care and health outcomes. The various professional regulatory bodies have mandated that registrants demonstrate an understanding of research, ethics and governance in order to apply research findings and inform best practice. Therefore, all staff working in health and social care are required to have an awareness of research as pertains to their practice. This session will explore how staff can incorporate research into their practice to make it business as usual.
inserts
Eye News April/May 2022Coming to terms with AI
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...Independent Opticians Win SightCare Excellence Awards at the 2022 SightCare Business & Networking Conference
14 February 2023
Six deserving independent optical practices were named as winners in the 2022 SightCare Awards celebrating the independent spirit.
Patients blinded by stem cells! How safe are they really?
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...What’s new in wet AMD papers?
1 December 2016
| Rod McNeil
|
EYE - Vitreo-Retinal
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...
Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service
3 April 2023
| Yasir Khan, Robin Hamilton, Adam Mapani, Catey Bunce, Ranjan Rajendram, Carlos Pavesio
|
EYE - General
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...
